LC-MS profiling and antidiabetic evaluation of ethanolic root extract of Asparagus curillus Buch.-Ham. ex Roxb. in streptozotocin-induced diabetic rats

Anoop Singh  Negi; Veerma  Ram; Ankit  Kumar

doi:10.69857/joapr.v14i2.1768

Authors

Anoop Singh Negi Department of Pharmacology, School of Pharmaceutical Sciences and Technology, Sardar Bhagwan Singh University, Balawala, 248161, Dehradun, Uttarakhand, India
Veerma Ram Department of Pharmacology, School of Pharmaceutical Sciences and Technology, Sardar Bhagwan Singh University, Balawala, 248161, Dehradun, Uttarakhand, India
Ankit Kumar College of Pharmacy, Shivalik Campus, Dehradun, 248197, India

DOI:

https://doi.org/10.69857/joapr.v14i2.1768

Keywords:

LC-ESI-MS/MS, Hyperglycemia, Insulin resistance, HOMA-IR, HbA1c, Liver function, Histopathology

Abstract

Background: Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia due to impaired insulin secretion or action and represents a major global health concern, with high prevalence in India. Although several antidiabetic drugs are available, their side effects and limited efficacy highlight the need for safer alternatives, such as traditionally used medicinal plants, such as Asparagus curillus. Methodology: This work used LC-MS to create the phytochemical profile of the ERE of A. curillus and tested for its anti-diabetic potential in STZ-induced diabetic rats. FBG level and biochemical markers, including lipid profile, insulin, HOMA-IR, liver and kidney function, and HbA1c, were measured. Kidney, liver, and pancreatic tissues were examined microscopically. Results & Discussion: LC-MS analysis identified twelve major phytoconstituents, mainly steroidal saponins including Shatavarin I, Shatavarin IV, and sarsasapogenin. The ERE produced dose-dependent changes in the biological parameters. At the dose of 200 mg/kg, ERE reduced FBG by 37% and HbA1c by 22%, while at 400 mg/kg, reductions of 42% in FBG and 25% in HbA1c were observed compared to the diabetic control. Histopathological examination of organs showed corresponding microscopic changes consistent with the biochemical findings. Conclusion: The ERE showed significant antidiabetic activity, improving glycemic indices, insulin sensitivity, lipid profile, and renal parameters, as supported by histopathological findings. LC-MS confirmed the presence of steroidal saponins, suggesting that the extract may serve as a potential natural antidiabetic agent. However, further studies are required to elucidate the mechanism and to validate it in clinical trials.

Downloads

Download data is not yet available.

References

Cefalu WT. Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents. Clin Pharmacol Ther, 81, 636–49 (2007) https://doi.org/10.1038/sj.clpt.6100245

Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, Roh EJ, Elkamhawy A, Al-Karmalawy AA. Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother, 168, 115734 (2023) https://doi.org/10.1016/j.biopha.2023.115734

Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int J Mol Sci, 22, 7644 (2021) https://doi.org/10.3390/ijms22147644

Adeva-Andany MM, Funcasta-Calderón R, Fernández-Fernández C, Castro-Quintela E, Carneiro-Freire N. Metabolic effects of glucagon in humans. J Clin Transl Endocrinol, 15, 45–53 (2019) https://doi.org/10.1016/j.jcte.2018.12.005

Negi AS, Ram V, Bisht L, Kumar R, Kumar A, Bajpai AB, Semwal DK. Evaluation of the effects of Zn/Mg supplemented diet as adjuvant therapy with glibenclamide on streptozotocin-induced diabetic rats. Curr Nutr Food Sci, 18, 597–603 (2022) https://doi.org/10.2174/1573401318666220304151421

Choudhury AA, Rajeswari VD. Gestational diabetes mellitus – a metabolic and reproductive disorder. Biomed Pharmacother, 143, 112183 (2021) https://doi.org/10.1016/j.biopha.2021.112183

Azizah N, Ghifari AA, Adikusuma W, Darmawi, Hamidy MY. Exploring the diverse therapeutic benefits of metformin: from anti-cancer to anti-inflammation and PCOS management. J Appl Pharm Res, 12(4), 1–10 (2024) https://doi.org/10.69857/joapr.v12i4.573

Berlanga-Acosta J, Schultz GS, López-Mola E, Guillen-Nieto G, García-Siverio M, Herrera-Martínez L. Glucose toxic effects on granulation tissue productive cells: the diabetics impaired healing. Biomed Res Int, 2013, 256043 (2013) https://doi.org/10.1155/2013/256043

Chowdhury NRA, Urme SA, Hridoy A, Nusrat F, Miah MS. Exploring the effects of catastrophic health expenditure due to non-communicable diseases and coping strategies: a case study among households in Bangladesh. Public Health Pract, 10, 100642 (2025) https://doi.org/10.1016/j.puhip.2025.100642

Babu BV, Hazarika CR, Raina SK, Masoodi SR, Basappa YC, Thomas N, Jebasingh FK. Prevalence of type 2 diabetes among tribal population of India: a multi-centric cross-sectional study. J Natl Med Assoc, 116, 153–64 (2024) https://doi.org/10.1016/j.jnma.2024.01.004

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 138, 271–81 (2018) https://doi.org/10.1016/j.diabres.2018.02.023

Kumar A, Aswal S, Chauhan A, Semwal RB, Kumar A, Semwal DK. Ethnomedicinal investigation of medicinal plants of Chakrata region (Uttarakhand) used in the traditional medicine for diabetes by Jaunsari tribe. Nat Prod Bioprospect, 9, 175–200 (2019) https://doi.org/10.1007/s13659-019-0202-5

Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, Török S, Pósa A, Varga C. Experimental diabetes mellitus in different animal models. J Diabetes Res, 2016, 9051426 (2016) https://doi.org/10.1155/2016/9051426

Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol, 70, 5.47.1–5.47.20 (2015) https://doi.org/10.1002/0471141755.ph0547s70

Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol, 56, 101–5 (2004) https://doi.org/10.1211/0022357022403

Shrestha R, Shakya A, Shrestha KK. Phytochemical screening and antimicrobial activity of Asparagus racemosus Willd. and Asparagus curillus Buch.-Ham. ex Roxb. J Nat Hist Mus, 29, 91–102 (2015) https://doi.org/10.3126/jnhm.v29i0.19041

Kumar M, Rawat S, Nagar B, Kumar A, Pala NA, Bhat JA, Bussmann RW, Pinto-Cabral M, Kunwar R. Implementation of the use of ethnomedicinal plants for curing diseases in the Indian Himalayas and its role in sustainability of livelihoods and socioeconomic development. Int J Environ Res Public Health, 18, 1509 (2021) https://doi.org/10.3390/ijerph18041509

Negi AS, Ram V, Kumar A. Pharmacognostic, phytochemical, and antioxidant investigations of Asparagus curillus Buch.-Ham. ex Roxb: ethnomedicinal species of the lower Himalayas. Int J Drug Deliv Technol, 14, 2004–12 (2024) https://doi.org/10.25258/ijddt.14.4.9

Paul A, Dutta PK, Khan ML, Das AK. Rhododendrons: a major resource of fuelwood in high altitude region of Arunachal Himalaya, India. Biodiversitas, 20, 2628–35 (2019) https://doi.org/10.13057/biodiv/d200927

Alara OR, Abdurahman NH, Ukaegbu CI, Kabbashi NA. Extraction and characterization of bioactive compounds in Vernonia amygdalina leaf ethanolic extract comparing Soxhlet and microwave-assisted extraction techniques. J Taibah Univ Sci, 13, 414–22 (2019) https://doi.org/10.1080/16583655.2019.1582460

Donato P, Cacciola F, Tranchida PQ, Dugo P, Mondello L. Mass spectrometry detection in comprehensive liquid chromatography: basic concepts, instrumental aspects, applications and trends. Mass Spectrom Rev, 31, 523–59 (2012) https://doi.org/10.1002/mas.20353

Jayashree GV, Kumar KH, Krupashree K, Rachitha P, Khanum F. LC–ESI–MS/MS analysis of Asparagus racemosus Willd. roots and its protective effects against t-BHP induced oxidative stress in rats. Ind Crops Prod, 78, 102–9 (2015) https://doi.org/10.1016/j.indcrop.2015.10.024

OECD. OECD guidelines for the testing of chemicals, Section 4. Paris: OECD Publishing; (2001) 1–14 https://doi.org/10.1787/9789264071001-en

Kumar A, Negi AS, Chauhan A, Semwal R, Kumar R, Semwal RB, Singh R, Joshi T, Chandra S, Joshi SK, Semwal DK. Formulation and evaluation of SGLT2 inhibitory effect of a polyherbal mixture inspired from Ayurvedic system of medicine. J Tradit Complement Med, 12, 477–87 (2022) https://doi.org/10.1016/j.jtcme.2022.03.003

Oraby MA, El-Yamany MF, Safar MM, Assaf N, Ghoneim HA. Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats. Biomed Pharmacother, 109, 910–20 (2019) https://doi.org/10.1016/j.biopha.2018.10.100

Ojo OA, Yakubu MT. Anti-diabetic activity of aqueous extract of Trichilia prieureana A. Juss leaves in fructose-fed streptozotocin-induced diabetic male Wistar rats. J Tradit Complement Med, 15, 509–21 (2025) https://doi.org/10.1016/j.jtcme.2024.07.006

Van Herck H, Baumans V, Brandt CJ, Boere HA, Hesp AP, Van Lith HA, Schurink M, Beynen AC. Blood sampling from the retro-orbital plexus, the saphenous vein and the tail vein in rats: comparative effects on selected behavioural and blood variables. Lab Anim, 35, 131–9 (2001) https://doi.org/10.1258/0023677011911499

Gupta V, Kori ML. Potential impact of novel polyherbal formulations on streptozotocin–nicotinamide induced diabetic Wistar rats. Res J Pharm Technol, 16, 1607–16 (2023) https://doi.org/10.52711/0974-360X.2023.00263

Pariyani R, Safinar Ismail I, Azam AA, Abas F, Shaari K, Sulaiman MR. Phytochemical screening and acute oral toxicity study of Java tea leaf extracts. Biomed Res Int, 2015, 742420 (2015) https://doi.org/10.1155/2015/742420

Ranaware AM, Nalawade SP. Phytochemical profiling and antioxidant assessment of Cassia auriculata leaves via GC-MS. J Appl Pharm Res, 13(3), 272–81 (2025) https://doi.org/10.69857/joapr.v13i3.1247

Davidge A, Bulat F, Vernet A. Evaluating cervical dislocation methods, without using tension on the tail, for humanely killing adult laboratory mice. Lab Anim, 59, 570–7 (2025) https://doi.org/10.1177/00236772251332722

Mansukhani M, Ganguli N, Majumdar SS, Sharma SS. Chronic oral exposure to chlorpyrifos disrupts hepatic epigenetic regulation and induces metabolic dysfunction in mice. Toxicology, 519, 154296 (2025) https://doi.org/10.1016/j.tox.2025.154296

Mitra SK, Prakash NS, Sundaram R. Shatavarins (containing Shatavarin IV) with anticancer activity from the roots of Asparagus racemosus. Indian J Pharmacol, 44, 732–6 (2012) https://doi.org/10.4103/0253-7613.103273

Smita SS, Sammi RS, Laxman TS, Bhatta RS, Pandey R. Shatavarin IV elicits lifespan extension and alleviates Parkinsonism in Caenorhabditis elegans. Free Radic Res, 51, 954–69 (2017) https://doi.org/10.1080/10715762.2017.1395419

Smita SS, Trivedi M, Tripathi D, Pandey-Rai S, Pandey R. Neuromodulatory potential of Asparagus racemosus and its bioactive molecule Shatavarin IV by enhancing synaptic acetylcholine level and nAChR activity. Neurosci Lett, 764, 136294 (2021) https://doi.org/10.1016/j.neulet.2021.136294

Bhandary BSK, Sharmila KP, Kumari NS, Bhat VS, Fernandes R. Acute and subacute toxicity profile of Asparagus racemosus root extract, isoprinosine and Shatvari syrup in Swiss albino mice. J Appl Pharm Sci, 7, 129–35 (2017) https://doi.org/10.7324/JAPS.2017.70523

Choudhary D, Naik SN, Tyagi V, Pal A, Hariprasad P. Toxicological evaluation of Asparagus racemosus–based low-alcohol nutraceutical beverage: acute and subacute safety assessment in mice. Sustain Food Technol, 3, 1439–49 (2025) https://doi.org/10.1039/D5FB00109A

Lazzaroni E, Lunati ME, Montefusco L, Pastore I, Chebat E, Cimino V, Morpurgo PS, Muratori M, Plebani L, Bolla A, Rossi A. Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus: the PRECARE study. Pharmacol Res, 183, 106374 (2022) https://doi.org/10.1016/j.phrs.2022.106374

Solanki JD, Makwana AH, Mehta HB, Gokhale PA, Shah CJ. Body composition in type 2 diabetes: change in quality and not just quantity that matters. Int J Prev Med, 6, 122 (2015) https://doi.org/10.4103/2008-7802.172376

Kim HJ, Lee HW, Kang MK, Leem GH, Kim MH, Song TJ. Association of body composition changes with the development of diabetes mellitus: a nation-wide population study. Diabetes Metab J, 48, 1093–1104 (2024) https://doi.org/10.4093/dmj.2023.0243

Tayek CJ, Cherukuri L, Hamal S, Tayek JA. Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal. J Diabetes Metab Disord Control, 5, 113–17 (2018) https://doi.org/10.15406/jdmdc.2018.05.00148

Jellinger PS. Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone, 8, S30–42 (2007) https://doi.org/10.1016/S1098-3597(07)80019-6

Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs, 73, 327–39 (2013) https://doi.org/10.1007/s40265-013-0023-5

Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Peña Genao E, Guzman E, Kostara CE. The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics, 13, 929 (2023) https://doi.org/10.3390/diagnostics13050929

Bhosle D, Sayyed A, Bhagat A, Sheikh H, Londhe V. Homeostasis model assessment of insulin resistance (HOMA-IR) in the diagnosis of insulin resistance and prediabetes. J Med Sci Clin Res, 4, 12705–10 (2016) http://dx.doi.org/10.18535/jmscr/v4i9.65

Mohamed J, Nafizah AN, Zariyantey AH, Budin S. Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. Sultan Qaboos Univ Med J, 16, e132–41 (2016) https://doi.org/10.18295/squmj.2016.16.02.002

Rafaqat S, Sattar A, Khalid A, Rafaqat S. Role of liver parameters in diabetes mellitus – a narrative review. Endocr Regul, 57, 200–20 (2023) https://doi.org/10.2478/enr-2023-0024

Wu T, Ding L, Andoh V, Zhang J, Chen L. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update. Life, 13, 539 (2023) https://doi.org/10.3390/life13020539

Voycheva P, Petkova-Parlapanska K, Georgieva E, Karamalakova Y, Nikolova G. Biomarkers of oxidative stress in diabetes mellitus with diabetic nephropathy complications. Int J Mol Sci, 24, 13541 (2023) https://doi.org/10.3390/ijms241713541

Yazdanpanah S, Rabiee M, Tahriri M, Abdolrahim M, Rajab A, Jazayeri HE, Tayebi L. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: a comprehensive review. Crit Rev Clin Lab Sci, 54, 219–32 (2017) https://doi.org/10.1080/10408363.2017.1299684

Berard LD, Siemens R, Woo V. Monitoring glycemic control. Can J Diabetes, 42, S47–53 (2018) https://doi.org/10.1016/j.jcjd.2017.10.007